Predictable synthetic bone grafting procedures for implant reconstruction: part two.
Identifieur interne : 003311 ( PubMed/Corpus ); précédent : 003310; suivant : 003312Predictable synthetic bone grafting procedures for implant reconstruction: part two.
Auteurs : Scott D. Ganz ; Maurice ValenSource :
- The Journal of oral implantology [ 0160-6972 ] ; 2002.
English descriptors
- KwdEn :
- Absorbable Implants, Aged, Alveolar Ridge Augmentation, Alveoloplasty, Animals, Biocompatible Materials (chemistry), Biocompatible Materials (therapeutic use), Biopsy, Bone Density, Bone Regeneration, Bone Substitutes (chemistry), Bone Substitutes (therapeutic use), Bone Transplantation, Cattle, Chemical Phenomena, Chemistry, Physical, Coloring Agents, Dental Implantation, Endosseous, Dental Implants, Dental Implants, Single-Tooth, Durapatite (chemistry), Durapatite (therapeutic use), Humans, Jaw, Edentulous, Partially (rehabilitation), Jaw, Edentulous, Partially (surgery), Male, Microscopy, Electron, Osteocytes (pathology), Osteotomy, Patient Care Planning.
- MESH :
- chemical , chemistry : Biocompatible Materials, Bone Substitutes, Durapatite.
- chemical , therapeutic use : Biocompatible Materials, Bone Substitutes, Durapatite.
- pathology : Osteocytes.
- rehabilitation : Jaw, Edentulous, Partially.
- surgery : Jaw, Edentulous, Partially.
- Absorbable Implants, Aged, Alveolar Ridge Augmentation, Alveoloplasty, Animals, Biopsy, Bone Density, Bone Regeneration, Bone Transplantation, Cattle, Chemical Phenomena, Chemistry, Physical, Coloring Agents, Dental Implantation, Endosseous, Dental Implants, Dental Implants, Single-Tooth, Humans, Male, Microscopy, Electron, Osteotomy, Patient Care Planning.
Abstract
When teeth are missing, the surrounding bone and soft tissue is challenged as a result of the natural resorptive process or from traumatic destruction subsequent to extraction. The diminished structural foundation for prosthetic reconstruction with or without implants can therefore be compromised. Recent technological innovations in computer hardware and software have given clinicians the tools to determine 3-dimensional anatomy, quality, and density of bone, which can aid in the diagnosis and treatment planning for reparative or augmentative grafting procedures. Advanced synthetic bioactive resorbable bone graft (SBRG) materials and innovative surgical techniques have made it possible to predictably alter the defective site to create favorable osseous conditions for implant placement. The synthetically derived, resorbable, cluster-like, hydrophilic, particulate, bone-grafting material, having similar mechanical and chemical properties as the host bone, can provide the means to modify existing bone topography by aggressively overpacking the material for ridge preservation, ridge augmentation, or to enhance the bony site and subsequent prosthetic rehabilitation. Since bone does not bridge in empty spaces, the aggressive overfill, commonly referred to as force mineralization, controls excessive bleeding and eliminates voids. Part 1 of this 2-part series presented evidence of safety and effectiveness of the SBRG materials, crystal morphology, chemical properties, and characterization through animal and clinical studies. The osteoconductive cluster particulate assists in the bridging of lost bone anatomy by chemotactic response and resorption concurrent with regeneration of new bone formations. Part 2 demonstrates specific clinical handling characteristics and use of this material to facilitate implant placement and/or prosthetic reconstruction through clinical case applications. Additionally, in a unique clinical presentation, a composite graft mixture consisting of the SBRG and dense, ceramic, bovine-derived HA (sintered at 1,150 degrees C) was compared using electron microscopy.
DOI: 10.1563/1548-1336(2002)028<0178:PSBGPF>2.3.CO;2
PubMed: 12498464
Links to Exploration step
pubmed:12498464Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Predictable synthetic bone grafting procedures for implant reconstruction: part two.</title><author><name sortKey="Ganz, Scott D" sort="Ganz, Scott D" uniqKey="Ganz S" first="Scott D" last="Ganz">Scott D. Ganz</name><affiliation><nlm:affiliation>Hackensack University Medical Center, NJ, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Valen, Maurice" sort="Valen, Maurice" uniqKey="Valen M" first="Maurice" last="Valen">Maurice Valen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2002">2002</date><idno type="RBID">pubmed:12498464</idno><idno type="pmid">12498464</idno><idno type="doi">10.1563/1548-1336(2002)028<0178:PSBGPF>2.3.CO;2</idno><idno type="wicri:Area/PubMed/Corpus">003311</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003311</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Predictable synthetic bone grafting procedures for implant reconstruction: part two.</title><author><name sortKey="Ganz, Scott D" sort="Ganz, Scott D" uniqKey="Ganz S" first="Scott D" last="Ganz">Scott D. Ganz</name><affiliation><nlm:affiliation>Hackensack University Medical Center, NJ, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Valen, Maurice" sort="Valen, Maurice" uniqKey="Valen M" first="Maurice" last="Valen">Maurice Valen</name></author></analytic><series><title level="j">The Journal of oral implantology</title><idno type="ISSN">0160-6972</idno><imprint><date when="2002" type="published">2002</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Absorbable Implants</term><term>Aged</term><term>Alveolar Ridge Augmentation</term><term>Alveoloplasty</term><term>Animals</term><term>Biocompatible Materials (chemistry)</term><term>Biocompatible Materials (therapeutic use)</term><term>Biopsy</term><term>Bone Density</term><term>Bone Regeneration</term><term>Bone Substitutes (chemistry)</term><term>Bone Substitutes (therapeutic use)</term><term>Bone Transplantation</term><term>Cattle</term><term>Chemical Phenomena</term><term>Chemistry, Physical</term><term>Coloring Agents</term><term>Dental Implantation, Endosseous</term><term>Dental Implants</term><term>Dental Implants, Single-Tooth</term><term>Durapatite (chemistry)</term><term>Durapatite (therapeutic use)</term><term>Humans</term><term>Jaw, Edentulous, Partially (rehabilitation)</term><term>Jaw, Edentulous, Partially (surgery)</term><term>Male</term><term>Microscopy, Electron</term><term>Osteocytes (pathology)</term><term>Osteotomy</term><term>Patient Care Planning</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Biocompatible Materials</term><term>Bone Substitutes</term><term>Durapatite</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Biocompatible Materials</term><term>Bone Substitutes</term><term>Durapatite</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Osteocytes</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Jaw, Edentulous, Partially</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Jaw, Edentulous, Partially</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Absorbable Implants</term><term>Aged</term><term>Alveolar Ridge Augmentation</term><term>Alveoloplasty</term><term>Animals</term><term>Biopsy</term><term>Bone Density</term><term>Bone Regeneration</term><term>Bone Transplantation</term><term>Cattle</term><term>Chemical Phenomena</term><term>Chemistry, Physical</term><term>Coloring Agents</term><term>Dental Implantation, Endosseous</term><term>Dental Implants</term><term>Dental Implants, Single-Tooth</term><term>Humans</term><term>Male</term><term>Microscopy, Electron</term><term>Osteotomy</term><term>Patient Care Planning</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">When teeth are missing, the surrounding bone and soft tissue is challenged as a result of the natural resorptive process or from traumatic destruction subsequent to extraction. The diminished structural foundation for prosthetic reconstruction with or without implants can therefore be compromised. Recent technological innovations in computer hardware and software have given clinicians the tools to determine 3-dimensional anatomy, quality, and density of bone, which can aid in the diagnosis and treatment planning for reparative or augmentative grafting procedures. Advanced synthetic bioactive resorbable bone graft (SBRG) materials and innovative surgical techniques have made it possible to predictably alter the defective site to create favorable osseous conditions for implant placement. The synthetically derived, resorbable, cluster-like, hydrophilic, particulate, bone-grafting material, having similar mechanical and chemical properties as the host bone, can provide the means to modify existing bone topography by aggressively overpacking the material for ridge preservation, ridge augmentation, or to enhance the bony site and subsequent prosthetic rehabilitation. Since bone does not bridge in empty spaces, the aggressive overfill, commonly referred to as force mineralization, controls excessive bleeding and eliminates voids. Part 1 of this 2-part series presented evidence of safety and effectiveness of the SBRG materials, crystal morphology, chemical properties, and characterization through animal and clinical studies. The osteoconductive cluster particulate assists in the bridging of lost bone anatomy by chemotactic response and resorption concurrent with regeneration of new bone formations. Part 2 demonstrates specific clinical handling characteristics and use of this material to facilitate implant placement and/or prosthetic reconstruction through clinical case applications. Additionally, in a unique clinical presentation, a composite graft mixture consisting of the SBRG and dense, ceramic, bovine-derived HA (sintered at 1,150 degrees C) was compared using electron microscopy.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12498464</PMID><DateCompleted><Year>2003</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0160-6972</ISSN><JournalIssue CitedMedium="Print"><Volume>28</Volume><Issue>4</Issue><PubDate><Year>2002</Year></PubDate></JournalIssue><Title>The Journal of oral implantology</Title><ISOAbbreviation>J Oral Implantol</ISOAbbreviation></Journal><ArticleTitle>Predictable synthetic bone grafting procedures for implant reconstruction: part two.</ArticleTitle><Pagination><MedlinePgn>178-83</MedlinePgn></Pagination><Abstract><AbstractText>When teeth are missing, the surrounding bone and soft tissue is challenged as a result of the natural resorptive process or from traumatic destruction subsequent to extraction. The diminished structural foundation for prosthetic reconstruction with or without implants can therefore be compromised. Recent technological innovations in computer hardware and software have given clinicians the tools to determine 3-dimensional anatomy, quality, and density of bone, which can aid in the diagnosis and treatment planning for reparative or augmentative grafting procedures. Advanced synthetic bioactive resorbable bone graft (SBRG) materials and innovative surgical techniques have made it possible to predictably alter the defective site to create favorable osseous conditions for implant placement. The synthetically derived, resorbable, cluster-like, hydrophilic, particulate, bone-grafting material, having similar mechanical and chemical properties as the host bone, can provide the means to modify existing bone topography by aggressively overpacking the material for ridge preservation, ridge augmentation, or to enhance the bony site and subsequent prosthetic rehabilitation. Since bone does not bridge in empty spaces, the aggressive overfill, commonly referred to as force mineralization, controls excessive bleeding and eliminates voids. Part 1 of this 2-part series presented evidence of safety and effectiveness of the SBRG materials, crystal morphology, chemical properties, and characterization through animal and clinical studies. The osteoconductive cluster particulate assists in the bridging of lost bone anatomy by chemotactic response and resorption concurrent with regeneration of new bone formations. Part 2 demonstrates specific clinical handling characteristics and use of this material to facilitate implant placement and/or prosthetic reconstruction through clinical case applications. Additionally, in a unique clinical presentation, a composite graft mixture consisting of the SBRG and dense, ceramic, bovine-derived HA (sintered at 1,150 degrees C) was compared using electron microscopy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ganz</LastName><ForeName>Scott D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Hackensack University Medical Center, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valen</LastName><ForeName>Maurice</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Oral Implantol</MedlineTA><NlmUniqueID>7801086</NlmUniqueID><ISSNLinking>0160-6972</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001672">Biocompatible Materials</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018786">Bone Substitutes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004396">Coloring Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015921">Dental Implants</NameOfSubstance></Chemical><Chemical><RegistryNumber>91D9GV0Z28</RegistryNumber><NameOfSubstance UI="D017886">Durapatite</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020341" MajorTopicYN="Y">Absorbable Implants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000540" MajorTopicYN="N">Alveolar Ridge Augmentation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000543" MajorTopicYN="N">Alveoloplasty</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001672" MajorTopicYN="N">Biocompatible Materials</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001861" MajorTopicYN="N">Bone Regeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018786" MajorTopicYN="N">Bone Substitutes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016025" MajorTopicYN="N">Bone Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055598" MajorTopicYN="N">Chemical Phenomena</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002627" MajorTopicYN="N">Chemistry, Physical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004396" MajorTopicYN="N">Coloring Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003758" MajorTopicYN="N">Dental Implantation, Endosseous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015921" MajorTopicYN="Y">Dental Implants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019250" MajorTopicYN="N">Dental Implants, Single-Tooth</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017886" MajorTopicYN="N">Durapatite</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007576" MajorTopicYN="N">Jaw, Edentulous, Partially</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010011" MajorTopicYN="N">Osteocytes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010027" MajorTopicYN="N">Osteotomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010347" MajorTopicYN="N">Patient Care Planning</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>25</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>3</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>25</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12498464</ArticleId><ArticleId IdType="doi">10.1563/1548-1336(2002)028<0178:PSBGPF>2.3.CO;2</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003311 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003311 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:12498464
|texte= Predictable synthetic bone grafting procedures for implant reconstruction: part two.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:12498464" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a EdenteV2
| This area was generated with Dilib version V0.6.32. |  |